John Doorbar (United Kingdom)
University of Cambridge Pathology
Presenter of 4 Presentations
HPV PROTEIN FUNCTIONS ARE LINKED TO THE DISTINCT HOMEOSTASIS MECHANISMS THAT REGULATE THEIR EPITHELIAL NICHES (ID 1273)
Session Time
10:00 - 17:00
Session Type
Poster Viewing - 20-24 July
Session Name
Basic Research / Virus Life Cycle
Lecture Time
10:01 - 10:02
Introduction
The sexually transmitted alpha HPV types infect distinct epithelial niches. We have examined the molecular pathways that regulate normal epithelial homeostasis at four genital target sites, including the vulva, the ectocervix, the cervical transformation zone and the endocervix in order to explain the evolution of high and low risk HPV protein functions, and their mode of HPV persistence.
Methods
Patterns of HPV gene expression in clinical biopsy material, have been correlated by multiplex immunofluoresence imaging with markers of epithelial homeostasis within the femalke genital tract. Molecular pathways were validated using in vitro tissue culture systems that model the epithelial basal layer and the process of reserve cell metaplasia.
Results
Epithelial differentiation controlled by p53 appears a common target of these viruses, which is mediated through the inhibition of p53 transcription, or through E6AP-binding and direct E6-mediated degradation. For high and low risk HPV types, tthis results in an inhibition of Notch-mediated commitment to differentiation, and the persistence of HPV infected cells in the basal layer because of their selective growth advantage. The specific ability of the high-risk HPV types to persist at the cervical transformation zone, requires interference with the molecular pathways that regulate reserve cell proliferation and metaplasia. The balance between Wnt and Notch signalling controls differentiation, quiescence and cell division at this site, with the Hippo pathway controlling cell density. E6 interferes with all three regulatory pthways to ensure persistence, with high risk E6 /PDZ domain protein interactions contributing additionally to disruption of normal cell-cell recognition.
Conclusions
HPV protein functions have evolved to modulatethe homeosatic pathways that regulate their specific epithelial target sites, which for high-risk HPV types includes the reserve cells of the cervical transformation zone. The deregulation of such 'normal ' HPV functions underlies the development of neoplasia. Regulators of HPV-modulated epithelial homeostasis are prime candidates for therapeutic development.
Hide
Introduction by Chairs (ID 67)
Session Time
09:00 - 10:25
Session Type
Basic Science
Lecture Time
09:00 - 09:03
Introduction by Chairs (ID 1718)
Session Time
10:30 - 12:05
Session Type
Plenary Session
Lecture Time
10:30 - 10:33
[{"name":"Introduction by Chairs \u003Csmall\u003E(ID 1718)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":1718,"presentation":"Introduction by Chairs \u003Csmall\u003E(ID 1718)\u003C\/small\u003E","session":"IPVC Plenary Session 4","presenter":"John Doorbar (United Kingdom)","photo":""},"playlist":[{"name":"Introduction by Chairs","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/52\/John Doorbar IPVC20 1718 Introduction by Chairs.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/ipvc20\/52\/John Doorbar IPVC20 1718 Introduction by Chairs.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/52\/1E77E6CD.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/52\/John Doorbar IPVC20 1718 Introduction by Chairs.vtt"}]}]
{"provider":"CTI","provider_live":0,"type":1,"code":"aE22UU0vC"}
[session]
[presentation]
[presenter]
Hide
How it works? HPV Life Cycle, Entry & Carcinogenesis (ID 40)
Session Time
09:00 - 10:25
Session Type
Interdisciplinary
Lecture Time
09:03 - 09:23
Moderator of 2 Sessions
Session Type
Basic Science
Session Time
09:00 - 10:25
Session Type
Plenary Session
Session Time
10:30 - 12:05
[{"name":"Introduction by Chairs \u003Csmall\u003E(ID 1718)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":1718,"presentation":"Introduction by Chairs \u003Csmall\u003E(ID 1718)\u003C\/small\u003E","session":"IPVC Plenary Session 4","presenter":"John Doorbar (United Kingdom)","photo":""},"playlist":[{"name":"Introduction by Chairs","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/52\/John Doorbar IPVC20 1718 Introduction by Chairs.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/ipvc20\/52\/John Doorbar IPVC20 1718 Introduction by Chairs.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/52\/1E77E6CD.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/52\/John Doorbar IPVC20 1718 Introduction by Chairs.vtt"}]},{"name":"Resource-appropriate immunotherapeutic approaches to the elimination of cervical cancer \u003Csmall\u003E(ID 108)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":108,"presentation":"Resource-appropriate immunotherapeutic approaches to the elimination of cervical cancer \u003Csmall\u003E(ID 108)\u003C\/small\u003E","session":"IPVC Plenary Session 4","presenter":"Corey Casper (United States of America)","photo":"https:\/\/cslide.ctimeetingtech.com\/global_storage\/media\/content\/ipvc20\/persons\/photos\/70.jpg"},"playlist":[{"name":"Resource-appropriate immunotherapeutic approaches to the elimination of cervical cancer","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/52\/Corey Casper, MD MPH - IPVC20 - 108 - Presentation Name Resource-appropriate immunotherapeutic approaches to the elimination of cervical cancer.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/ipvc20\/52\/Corey Casper, MD MPH - IPVC20 - 108 - Presentation Name Resource-appropriate immunotherapeutic approaches to the elimination of cervical cancer.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/52\/5CE2E304.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/52\/Corey Casper, MD MPH - IPVC20 - 108 - Presentation Name Resource-appropriate immunotherapeutic approaches to the elimination of cervical cancer.vtt"}]},{"name":"Use of Deep Learning into Cervical Cancer Screening \u003Csmall\u003E(ID 109)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":109,"presentation":"Use of Deep Learning into Cervical Cancer Screening \u003Csmall\u003E(ID 109)\u003C\/small\u003E","session":"IPVC Plenary Session 4","presenter":"Mark Schiffman (United States of America)","photo":"https:\/\/cslide.ctimeetingtech.com\/global_storage\/media\/content\/ipvc20\/persons\/photos\/46.jpg"},"playlist":[{"name":"Use of Deep Learning into Cervical Cancer Screening","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/52\/IPVC 20 - Mark Schiffman - P109 - S1000.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/ipvc20\/52\/IPVC 20 - Mark Schiffman - P109 - S1000.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/52\/A153D5DD.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/52\/IPVC 20 - Mark Schiffman - P109 - S1000.vtt"}]},{"name":"Oral Cancer Therapeutics \u003Csmall\u003E(ID 110)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":110,"presentation":"Oral Cancer Therapeutics \u003Csmall\u003E(ID 110)\u003C\/small\u003E","session":"IPVC Plenary Session 4","presenter":"Robert L. Ferris (United States of America)","photo":"https:\/\/cslide.ctimeetingtech.com\/global_storage\/media\/content\/ipvc20\/persons\/photos\/112.jpg"},"playlist":[{"name":"","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/52\/PRESENTATION id 110.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/ipvc20\/52\/PRESENTATION id 110.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/52\/A823A273.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/52\/PRESENTATION id 110.vtt"}]}]
{"type":2,"code":"aE32UU0U"}
[session]
[presentation]
[presenter]